Advance in the Treatment of Acute Heart Failure Identified

A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new t

Related Keywords

United States ,America ,William Stubblefield ,Christina Kampe ,Cathy Jenkins ,Karen Miller ,Zachary Cox ,Frank Harrell Jr ,Sean Collins ,Joann Lindenfeld ,Public Health ,Vanderbilt Institute For Medicine ,Lipscomb University College Of Pharmacy ,Astrazeneca ,Vanderbilt University Medical Center ,Heart Failure Society Of America ,Health Baptist Medical Center ,University Of North Carolina At Chapel Hill ,Emergency Care Research ,Department Of Biostatistics ,Department Of Emergency Medicine ,Division Of Cardiology ,Tristar Centennial Medical Center ,Journal Of The American College Cardiology ,Vanderbilt Coordinating Center ,Pharmacy Practice At Lipscomb University ,University Of Mississippi Medical Center ,National Heart ,Lipscomb University College ,American College ,Pharmacy Practice ,Ann Lindenfeld ,Emergency Medicine ,Vanderbilt Institute ,Heart Failure Society ,Thomas Hospital West ,North Carolina ,Chapel Hill ,Mississippi Medical Center ,Baptist Medical Center ,Guideline Directed Medical Therapy ,Blood Institute ,National Institutes ,Newswise ,Eart Failure Dapagliflozin Type 2 Diabetes ,All Journal News ,Cardiovascular Health ,Diabetes ,Health Disparities ,Heart Disease ,Kidney Disease ,